Sigma-Tau
Sigma-Tau & Danisco to Develop Drug Candidate for Prevention of Necrotizing Enterocolitis
Submitted by pamelan on Tue, 04/07/2009 - 23:07Sigma-Tau Pharmaceuticals, Inc. and Danisco BioActives announced today that they have signed a partnering agreement for the development of a new biologic drug candidate, which may help to prevent a deadly disease called necrotizing enterocolitis (NEC).
